Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Dicrotophos |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01050
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Pesticide/Insecticide |
DME Modulation |
Dicrotophos up-regulates the expression of DME ANPEP |
[1] |
Health or Environmental Toxicant(s) |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 inhibits the expression of DME ANPEP |
[2] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 15 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME ANPEP |
[3] |
Arsenic trioxide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Arsenic trioxide inhibits the expression of DME ANPEP |
[4] |
Aspirin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00213
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Aspirin induces the drug-metabolizing activity of DME ANPEP |
[5] |
Cisplatin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin inhibits the expression of DME ANPEP |
[6] |
Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate inhibits the expression of DME ANPEP |
[7] |
Cupric chloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00407
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cupric chloride inhibits the expression of DME ANPEP |
[8] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME ANPEP |
[9] |
Dasatinib |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00181
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Dasatinib inhibits the drug-metabolizing activity of DME ANPEP |
[10] |
Decitabine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00168
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Decitabine up-regulates the expression of DME ANPEP |
[11] |
Diethylstilbestrol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00166
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Diethylstilbestrol up-regulates the expression of DME ANPEP |
[12] |
Methotrexate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00366
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Methotrexate up-regulates the expression of DME ANPEP |
[13], [14] |
Mifepristone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00127
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Mifepristone inhibits the drug-metabolizing activity of DME ANPEP |
[15] |
Troglitazone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00086
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Troglitazone up-regulates the expression of DME ANPEP |
[16] |
Zoledronic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00140
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Zoledronic acid up-regulates the expression of DME ANPEP |
[17] |
Rotenone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00481
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Rotenone up-regulates the expression of DME ANPEP |
[18], [19] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Fenretinide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00565
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Fenretinide inhibits the drug-metabolizing activity of DME ANPEP |
[20] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
ICG-001 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
ICG-001 inhibits the expression of DME ANPEP |
[21] |
K-7174 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
K-7174 inhibits the expression of DME ANPEP |
[22] |
Other Chemical Compound(s) or Element(s) |
Chemical Compound |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
1,10-phenanthroline |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00766
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Chemical Compound |
DME Modulation |
1,10-phenanthroline inhibits the drug-metabolizing activity of DME ANPEP |
[23] |
|
|
|
|
|
|